Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nanomedicine : nanotechnology, biology, and medicine

• Publication date

  2016-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nano.2015.10.021PMID 26711963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liposome-Based Drug Delivery Systems

  2021cited by this paper
• A Method of Effectively Improved α-Mangostin Bioavailability

  2015cited by this paper
• Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants

  2014cited by this paper
• Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome.

  2013cited by this paper
• Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.

  2013cited by this paper
• Microsphere-based flow cytometric immunoassay for the determination of citrinin in red yeast rice.

  2012cited by this paper
• Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.

  2012cited by this paper
• Murine in vitro model of the blood-brain barrier for evaluating drug transport.

  2011cited by this paper
• PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.

  2011cited by this paper
• Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain.

  2011cited by this paper
• The Blood–Brain Barrier Permeability of Geissoschizine Methyl Ether in Uncaria Hook, a Galenical Constituent of the Traditional Japanese Medicine Yokukansan

  2011cited by this paper
• Co-culture Based Blood-brain Barrier In Vitro Model, a Tissue Engineering Approach using Immortalized Cell Lines for Drug Transport Study

  2011cited by this paper
• Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations

  2010cited by this paper
• Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

  2010cited by this paper
• Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.

  2010cited by this paper
• ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons.

  2009cited by this paper
• Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

  2009cited by this paper
• Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

  2009cited by this paper
• Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.

  2009cited by this paper
• Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging.

  2008cited by this paper
• Intravenous glial‐derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter

  2008cited by this paper
• Anti-inflammatory activity of mangostins from Garcinia mangostana.

  2008cited by this paper
• Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.

  2008cited by this paper
• Blood-Brain Barrier Genomics

  2007cited by this paper
• Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

  2007cited by this paper
• In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.

  2006cited by this paper
• Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.

  2006cited by this paper
• Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil

  2005cited by this paper
• Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies.

  2003cited by this paper
• Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin

  2003cited by this paper
• Lipoprotein receptors in the nervous system.

  2002cited by this paper
• Transferrin/transferrin receptor‐mediated drug delivery

  2002cited by this paper
• [In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel].

  2002cited by this paper
• Polymer Vesicles

  2002cited by this paper
• In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.

  2001cited by this paper
• BBB-Genomics: creating new openings for brain-drug targeting.

  2001cited by this paper
• Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo

  2001cited by this paper
• Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin

  2000cited by this paper
• Liposome-based drug delivery systems.

  1999cited by this paper
• Pharmacological properties of alpha-mangostin, a novel histamine H1 receptor antagonist.

  1996cited by this paper
• Comparative Study of Separation of Non‐encapsulated Drug from Unilamellar Liposomes by Various Methods

  1996cited by this paper
• Pharmacological properties of α-mangostin, a novel histamine H1 receptor antagonist

  1996cited by this paper
• Brain Delivery of Biotin Bound to a Conjugate of Neutral Avidin and Cationized Human Albumin

  1994cited by this paper
• Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of Action

  1993cited by this paper
• Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier

  1987cited by this paper
• Transferrin receptor on endothelium of brain capillaries

  1984cited by this paper

• Utilizing nanotechnology to diagnose and treat central nervous system disorders

  2026cites this paper
• Brain targeted drug delivery using liposomes and polymeric nanocarriers: Pharmaceutical and preclinical perspectives in Alzheimer's and Parkinson's disease

  2026cites this paper
• Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches

  2025cites this paper
• The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial

  2025cites this paper
• A Review on QbD-Driven Optimization of Lipid Nanoparticles for Oral Drug Delivery: From Framework to Formulation

  2025cites this paper
• Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy.

  2025cites this paper
• The α-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells.

  2025cites this paper
• Nanotherapeutic Strategies for Overcoming the Blood–Brain Barrier: Applications in Disease Modeling and Drug Delivery

  2025cites this paper
• Unravelling Alpha-Mangostin as a Promising Anticancer Agent: An Overview of Therapeutic Effects, Molecular Mechanisms, and Strategies to Improve Treatment Outcomes

  2025influential citation
• QbD In Solid Lipid Nanoparticles To Enhance Blood-Brain Barrier Permeation For Alzheimer’s Therapy

  2025cites this paper
• Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

  2024cites this paper
• Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease

  2024cites this paper
• Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke

  2024cites this paper
• A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus

  2024cites this paper
• Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy

  2024cites this paper
• Preparation and Pharmacokinetics of Brain-Targeted Nanoliposome Loaded with Rutin

  2024cites this paper
• Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease.

  2024cites this paper
• Recent advances in delivering mangosteen-based phytochemicals using promising micro/nanocarriers: Formulation, outcomes, and perspectives

  2024cites this paper
• Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety

  2024influential citation
• Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability

  2024cites this paper
• Geriatric drug delivery ― barriers, current technologies and the road ahead

  2024cites this paper
• The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment.

  2024cites this paper
• Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates.

  2024cites this paper
• Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer

  2024cites this paper
• Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options

  2023cites this paper
• Fabrication of α-mangostin – loaded liposomes for cytotoxic-activity against A549 lung-cancer spheroids

  2023cites this paper
• A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms

  2023cites this paper
• Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development

  2023cites this paper
• Long-Term and Stable Dental Therapies via an In Situ Spontaneous Medicine Delivery System

  2023cites this paper
• Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression

  2023cites this paper
• Recent progress of nanomedicine in the treatment of Alzheimer’s disease

  2023cites this paper
• Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases

  2023cites this paper
• Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes

  2023cites this paper
• Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy.

  2023cites this paper
• Interactions of Graphene Oxide and Few-Layer Graphene with the Blood–Brain Barrier

  2023cites this paper
• Neuro-Nutraceutical Polyphenols: How Far Are We?

  2023cites this paper
• Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation

  2023cites this paper
• Strategic nanocarriers to control neurodegenerative disorders: concept, challenges, and future perspective.

  2023cites this paper
• Recent advances in lipid-protein conjugate-based delivery systems in nutraceutical, drug, and gene delivery

  2022cites this paper
• A Promising Ultra-Small Unilamellar Carrier System for Enhanced Skin Delivery of α-Mangostin as an Anti-Age-Spot Serum

  2022cites this paper
• Protective effects of alpha-mangostin encapsulated in cyclodextrin-nanoparticle on cerebral ischemia.

  2022cites this paper
• Nanodelivery of antiretroviral drugs to nervous tissues

  2022cites this paper
• Transferrin-Functionalized Liposomes for the Delivery of Gallic Acid: A Therapeutic Approach for Alzheimer’s Disease

  2022cites this paper
• Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease

  2022cites this paper
• Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier.

  2022cites this paper
• The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system.

  2022cites this paper
• Recent Trend of Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's disease.

  2022cites this paper
• Review of Current Strategies for Delivering Alzheimer's Disease Drugs Across the Blood-Brain Barrier.

  2022cites this paper
• A review of glucoregulatory hormones potentially applicable to the treatment of Alzheimer’s disease: mechanism and brain delivery

  2022cites this paper
• Lipoprotein-Inspired Nanoscavenger for the Three-Pronged Modulation of Microglia-Derived Neuroinflammation in Alzheimer's Disease Therapy.

  2022cites this paper
• How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?

  2022cites this paper
• Phytonutrients and Technological Development in Formulations

  2022cites this paper
• Ways to enhance the bioavailability of polyphenols in the brain: A journey through the blood-brain barrier

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021cites this paper
• A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease.

  2021cites this paper
• Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts

  2021cites this paper
• Are third-generation active-targeting nanoformulations definitely the best? In vitro and in vivo comparisons of pixantrone-loaded liposomes modified with different sialic acid derivatives

  2021cites this paper
• Curcumin loaded drug delivery systems in the treatment of Alzheimer’s disease

  2021cites this paper
• New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease

  2021cites this paper
• Targeted Drug Delivery: Trends and Perspectives.

  2021cites this paper
• Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer’s disease models

  2021cites this paper
• Brain-targeted drug delivery assisted by physical techniques and its potential applications in traditional Chinese medicine

  2021cites this paper
• Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

  2021cites this paper
• Rabies virus glycoprotein- and transferrin-functionalized liposomes to elevate epigallocatechin gallate and FK506 activity and mediate MAPK against neuronal apoptosis in Parkinson's disease

  2021cites this paper
• Efficiency of lipid-based nano drug delivery systems in crossing the blood-brain barrier: a review

  2021cites this paper
• Recent approaches and success of liposome-based nanodrug carriers for the treatment of brain tumor.

  2021cites this paper
• Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases

  2020cites this paper
• Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina.

  2020cites this paper
• Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.

  2020cites this paper
• Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview

  2020cites this paper
• The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies

  2020cites this paper
• Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases

  2020cites this paper
• Liposomes vs Phytosomes: Principles, Methodologies, and Therapeutic Applications with Emphasis on CNS Disorders

  2020cites this paper
• Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer’s Disease, Parkinson’s Disease, and Depression with Pharmacokinetic and Safety Profiles

  2020cites this paper
• Crossing the Blood-Brain-Barrier: A bifunctional liposome for BDNF gene delivery – A Pilot Study

  2020cites this paper
• A Natural Xanthone α-Mangostin Inhibits LPS-Induced Microglial Inflammatory Responses and Memory Impairment by Blocking the TAK1/NF-κB Signaling Pathway.

  2020cites this paper
• In Vitro and In Vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.

  2020cites this paper
• Actively targeted gold nanoparticle composites improve behavior and cognitive impairment in Parkinson's disease mice.

  2020cites this paper
• Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours.

  2020cites this paper
• Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice

  2020cites this paper
• Multiple-component dual-phase solid lipid nanoparticles with conjugated transferrin for formulating antioxidants and nerve growth factor against neuronal apoptosis

  2020cites this paper
• Understanding the In Vivo Fate of Advanced Materials by Imaging

  2020cites this paper
• Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's Disease.

  2020cites this paper
• Nanoparticle Drug Delivery Systems for α-Mangostin

  2020cites this paper
• Axial Pharmaceutical Properties of Liposome in Cancer Therapy: Recent Advances and Perspectives.

  2020cites this paper
• Liposomes as Brain Targeted Delivery Systems

  2020cites this paper
• Liposomal maneuvers against Parkinson's disease

  2020cites this paper
• Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor

  2020cites this paper
• Brain drug delivery: overcoming the blood-brain barrier to treat tauopathies.

  2020cites this paper
• Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.

  2020cites this paper
• Efficient neuronal targeting and transfection using RVG and Transferrin-conjugated liposomes.

  2020cites this paper
• Neuronanomedicine: An Up-to-Date Overview

  2019cites this paper
• α-Mangostin suppresses NLRP3 inflammasome activation via promoting autophagy in LPS-stimulated murine macrophages and protects against CLP-induced sepsis in mice

  2019cites this paper
• Nanobiotechnology in Neurodegenerative Diseases

  2019cites this paper
• Approaches in Barriers, Modifications, Route of Administrations, and Formulations of Therapeutic Agents for Brain Delivery

  2019cites this paper
• The Mechanism of Nano-drug Delivery

  2019cites this paper